Moonlight AI is a Swiss startup created to democratize access to essential genomic information for therapy decision-making in the era of personalized medicine.
Subscribe to see Moonlight AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Moonlight AI is a decision/risk company headquartered in Switzerland. Its most recent funding round, Seed, raised $3.3M in May 2026. Xcout tracks 6 named people at Moonlight AI, including Christian Ruiz (CEO/CSO (Chief Executive Officer)).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.3M | 5 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Moonlight AI's closest competitors — see the full list of competitors and alternatives →
QurieGen is a precision medicine company headquartered in Nijmegen, Netherlands, that uses single-cell AI to transform drug development and create treatments more efficiently.
Cassidy Bio is an AI-first biotechnology company founded in 2024 and based in Israel that is developing a programmable platform for gene editing. The company utilizes a genomic foundation model powered by artificial intelligence to design safer and more scalable gene editing therapies across various guides, editors, and delivery contexts.
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Cellyrix Therapeutics is an Israeli biotechnology company that develops targeted cancer therapies by leveraging single-cell RNA sequencing and artificial intelligence. The firm operates as an oncology-focused drug discovery venture headquartered in Rehovot, Israel.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.